Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Göran Walldius

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Diabetes, Obesity & Metabolism|February 6, 2018
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS studyHåkan Malmström, Göran Walldius, Sofia Carlsson, et al.
Diabetes Care|December 8, 2021
Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS CohortKatharina Herzog, Tomas Andersson, Valdemar Grill, et al.
Heart (British Cardiac Society)|February 6, 2025
Dysglycaemia and incident aortic stenosis: a cohort studyViktor Lind, Pia Lundman, Leif Friberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2011
Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyMieke Van Hemelrijck, Lars Holmberg, Hans Garmo, et al.
BMC Cancer|May 28, 2013
Inorganic phosphate and the risk of cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
BMC Cancer|February 22, 2018
Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohortCecilia Bosco, Hans Garmo, Niklas Hammar, et al.
Cancer Epidemiology|August 28, 2019
Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS CohortIoannis Peppas, Sam Sollie, Debra H Josephs, et al.
Plos Medicine|December 1, 2021
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-Experience from the Swedish AMORIS cohort: A cohort studyGöran Walldius, Ulf de Faire, Lars Alfredsson, et al.
Atherosclerosis|September 22, 2009
Levels of lipids and apolipoproteins in three culturesAmirreza Solhpour, Sahar Parkhideh, Nizal Sarrafzadegan, et al.
BMC Cancer|April 6, 2017
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohortJennifer C Melvin, Hans Garmo, Lars Holmberg, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|February 6, 2018
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS studyHåkan Malmström, Göran Walldius, Sofia Carlsson, et al.
Diabetes Care|December 8, 2021
Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS CohortKatharina Herzog, Tomas Andersson, Valdemar Grill, et al.
Heart (British Cardiac Society)|February 6, 2025
Dysglycaemia and incident aortic stenosis: a cohort studyViktor Lind, Pia Lundman, Leif Friberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2011
Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyMieke Van Hemelrijck, Lars Holmberg, Hans Garmo, et al.
BMC Cancer|May 28, 2013
Inorganic phosphate and the risk of cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
BMC Cancer|February 22, 2018
Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohortCecilia Bosco, Hans Garmo, Niklas Hammar, et al.
Cancer Epidemiology|August 28, 2019
Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS CohortIoannis Peppas, Sam Sollie, Debra H Josephs, et al.
Plos Medicine|December 1, 2021
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-Experience from the Swedish AMORIS cohort: A cohort studyGöran Walldius, Ulf de Faire, Lars Alfredsson, et al.
Atherosclerosis|September 22, 2009
Levels of lipids and apolipoproteins in three culturesAmirreza Solhpour, Sahar Parkhideh, Nizal Sarrafzadegan, et al.
BMC Cancer|April 6, 2017
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohortJennifer C Melvin, Hans Garmo, Lars Holmberg, et al.
Pageof 8